Since LAM muscle cells express two lymphangiogenic growth factors—vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D)—and disseminate through the lymphatic system, LAM is considered a low-grade metastatic neoplasm. This evidence concerns the gene VEGFC and metastatic neoplasm.